Sileikis Audrius, Beiša Augustas, Zdanytè Elena, Jurevičius Saulius, Strupas Kęstutis
Clinic of Gastroenterology, Nephrology and Surgery, Medical Faculty, Vilnius University, Lithuania.
Wideochir Inne Tech Maloinwazyjne. 2013 Sep;8(3):211-5. doi: 10.5114/wiitm.2011.33809. Epub 2013 May 27.
The laparoscopic and endoscopic approaches to internal drainage of pancreatic pseudocysts (PP) are the current minimally invasive management options. Indications, and early and late results of endoscopic and laparoscopic approaches are being discussed.
To present experience in treatment of PP by laparoscopic pseudocystogastrostomy (LPGS) and endoscopic pseudocystogastrostomy (EPGS) and to compare results, feasibility and safety.
THIRTY PATIENTS UNDERWENT SURGICAL INTERVENTION: 18 patients - LPGS (group I), 12 - EPGS (group II). Groups were compared by age, gender, pancreatic pseudocysts's age, diameter and localization, as well as intraoperative, early and late postoperative complications.
GENDER DISTRIBUTION, GROUP I: 14 (77.8%) men and 4 (22.2%) women, group II: 4 (33.3%) men and 8 (66.7%) women, p = 0.02. Average cyst diameter: group I - 149.9 ±52.1 mm, group II - 119 ±37.9 mm, p = 0.07. Average time between diagnosis and operation performance: group I - 12 (3-60) months, group II - 8 (2-36) months, p = 0.19. Neither in group I nor in group II did intraoperative complications occur. Early postoperative complications were divided into minor and major. Early minor complications: group I - 2 (11.1%), group II - 0, p = 0.5. Early major complications: group I - 0, group II - 2 (16.7%), p = 0.15. Late postoperative complications: group I - 0, group II - 1 (8.3%), p = 0.4. In group I there was no case, whereas in II group there was 1 (8.3%) case of recidivation, p = 0.4.
For selected patients both minimally invasive methods are equally safe an effective. For comprehensive evaluation of methods prospective trials are needed.
腹腔镜和内镜下胰腺假性囊肿(PP)内引流术是目前的微创治疗选择。目前正在讨论内镜和腹腔镜治疗方法的适应症以及早期和晚期结果。
介绍腹腔镜假性囊肿胃造口术(LPGS)和内镜下假性囊肿胃造口术(EPGS)治疗PP的经验,并比较其结果、可行性和安全性。
30例患者接受了手术干预:18例患者行LPGS(I组),12例患者行EPGS(II组)。通过年龄、性别、胰腺假性囊肿的病程、直径和位置,以及术中、术后早期和晚期并发症对两组进行比较。
性别分布,I组:男性14例(77.8%),女性4例(22.2%);II组:男性4例(33.3%),女性8例(66.7%),p = 0.02。平均囊肿直径:I组 - 149.9±52.1mm,II组 - 119±37.9mm,p = 0.07。诊断与手术之间的平均时间:I组 - 12(3 - 60)个月,II组 - 8(2 - 36)个月,p = 0.19。I组和II组均未发生术中并发症。术后早期并发症分为轻微和严重并发症。术后早期轻微并发症:I组 - 2例(11.1%),II组 - 0例,p = 0.5。术后早期严重并发症:I组 - 0例,II组 - 2例(16.7%),p = 0.15。术后晚期并发症:I组 - 0例,II组 - 1例(8.3%),p = 0.4。I组无复发病例,而II组有1例(8.3%)复发病例,p = 0.4。
对于选定的患者,两种微创方法同样安全有效。需要进行前瞻性试验以全面评估这些方法。